Amid global recession fears, Lauder anticipates continued double-digit growth in fiscal 2020 in China and travel retail, albeit at slower rates than seen in recent years. The firm booked 9% reported sales growth to roughly $14.9bn for the fiscal 2019 full year, fueled by a record-setting innovation program.
US-China trade tensions, protests in Hong Kong and the prospect of a no-deal Brexit are among risk factors with potential bearing on the [Estee Lauder Companies Inc.]’s fiscal 2020 performance, but leadership still is targeting 7% to 8% growth in reported sales for the year.
That would be just shy of the 9% overall growth Lauder reported 19 August for fiscal 2019, with global sales...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
